Adaptimmune Therapeutics PLC Price Chart
Adaptimmune Therapeutics PLC 473A.BE Financial and Trading Overview
| Adaptimmune Therapeutics PLC stock price | 1.03 EUR |
| Previous Close | 0.95 EUR |
| Open | 0.93 EUR |
| Bid | 0.76 EUR x 0 |
| Ask | 1.09 EUR x 0 |
| Day's Range | 0.93 - 0.93 EUR |
| 52 Week Range | 0.92 - 2.5 EUR |
| Volume | 2.75K EUR |
| Avg. Volume | 0 EUR |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
473A.BE Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Adaptimmune Therapeutics PLC Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 2.5 EUR |
| 52 Week Low | 0.92 EUR |
| 50-Day Moving Average | 1.13 EUR |
| 200-Day Moving Average | 1.46 EUR |
473A.BE Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | N/A |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | N/A |
| Operating Margin (ttm) | N/A |
| Gross Margin | N/A |
| EBITDA Margin | N/A |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Q&A For Adaptimmune Therapeutics PLC Stock
What is a current 473A.BE stock price?
Adaptimmune Therapeutics PLC 473A.BE stock price today per share is 1.03 EUR.
How to purchase Adaptimmune Therapeutics PLC stock?
You can buy 473A.BE shares on the Berlin exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Adaptimmune Therapeutics PLC?
The stock symbol or ticker of Adaptimmune Therapeutics PLC is 473A.BE.
How many shares does Adaptimmune Therapeutics PLC have in circulation?
The max supply of Adaptimmune Therapeutics PLC shares is 0.
What is Adaptimmune Therapeutics PLC Price to Earnings Ratio (PE Ratio)?
Adaptimmune Therapeutics PLC PE Ratio is now.
What was Adaptimmune Therapeutics PLC earnings per share over the trailing 12 months (TTM)?
Adaptimmune Therapeutics PLC EPS is 0 EUR over the trailing 12 months.